Not indicated for control of hyperparathyroidism. Multiple therapeutic approach in secondary hyperparathyroidism. Not recommended in CKD adult patients not on dialysis w/ serum P <1.78 mmol/L. Dysphagia; swallowing disorders; severe GI motility disorders including untreated or severe gastroparesis, gastric contents retention, abnormal or irregular bowel motion; active inflammatory bowel disease; major GIT surgery; intestinal obstruction & ileus/subileus; hypo- or hypercalcaemia, metabolic acidosis; hypothyroidism; inflammatory GI disorders. Carefully monitor patients w/ constipation. Closely monitor patients undergoing peritoneal dialysis. Assess serum vit A, D, E & K status, folate levels regularly. Monitor serum Ca & bicarbonate levels during treatment. Not to be taken by patients w/ galactose intolerance, total lactase deficiency or glucose-galactose malabsorption. Pregnancy & lactation.
Sign Out
